Literature DB >> 7539036

T cell determinants from autoantibodies to DNA can upregulate autoimmunity in murine systemic lupus erythematosus.

R R Singh1, V Kumar, F M Ebling, S Southwood, A Sette, E E Sercarz, B H Hahn.   

Abstract

(NZB x NZW) F1 (BWF1) mice develop spontaneous T cell autoimmunity to VH region determinants of syngeneic anti-DNA before the onset of clinical disease. In this study, we characterized the immunogenicity, MHC binding, and lymphokine secretion patterns induced by T cell determinants from the VH region of one such anti-DNA mAb (A6.1) and examined their role in the regulation of autoimmunity. Determinants were identified by proliferation of syngeneic splenic T cells from young, unprimed BWF1 mice in response to overlapping 12-mer peptides representing the entire VH region sequence. Immunization of young BWF1 mice with any of three determinants (A6H 34-45 [p34], A6H 58-69 [p58], and A6H 84-95 [p84]) elicited proliferative responses upon in vitro recall. Upon immunization with the whole A6.1 molecule, however, proliferative responses could be recalled only to the p58 peptide, defining this as immunodominant. The other two peptides (p34 and p84) elicited minimal or no proliferation and could be termed cryptic. Proliferative responses elicited by the cryptic determinants were restricted by a single class II (I-Ed for p34 and I-Au for p84), whereas the immunodominant p58 determinant was restricted by both I-Ed and I-Eu. The cryptic p34 and p84 bound strongly to I-Ed and I-Au, respectively, whereas the immunodominant p58 peptide bound poorly to I-Ed. A6H p84 elicited T cells that secreted lymphokines in a pattern consistent with a Th1-like phenotype, whereas p58 induced a Th2-like cytokine pattern. Immunization with p34 or p84, or adoptive transfer of a p84-reactive T cell line to young BWF1 mice significantly increased IgG anti-DNA levels, accelerated nephritis, and decreased survival. In conclusion, in BWF1 mice, autoreactive T cells recognizing both cryptic and dominant self-determinants on anti-DNA autoantibodies escape deletion or anergy induction. Furthermore, since these cells are spontaneously activated before the onset of clinical disease, they may be involved in the development of the autoimmune process.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7539036      PMCID: PMC2192064          DOI: 10.1084/jem.181.6.2017

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  40 in total

1.  Cryptic T cell epitopes in polymorphic immunoglobulin regions: evidence for positive repertoire selection during fetal development.

Authors:  J J Chen; S V Kaveri; H Kohler
Journal:  Eur J Immunol       Date:  1992-12       Impact factor: 5.532

2.  Subjugation of dominant immunogenic determinants within a chimeric peptide.

Authors:  V Bhardwaj; V Kumar; H M Geysen; E E Sercarz
Journal:  Eur J Immunol       Date:  1992-08       Impact factor: 5.532

3.  T cell epitope selection: dominance may be determined by both affinity for major histocompatibility complex and stoichiometry of epitope.

Authors:  W F Li; M D Fan; C B Pan; M Z Lai
Journal:  Eur J Immunol       Date:  1992-04       Impact factor: 5.532

Review 4.  Theoretical and experimental approaches to generalized autoimmunity.

Authors:  A D Steinberg; A M Krieg; M F Gourley; D M Klinman
Journal:  Immunol Rev       Date:  1990-12       Impact factor: 12.988

5.  Misinterpretation of results of cytokine bioassays.

Authors:  N Chirmule; N Oyaizu; V S Kalyanaraman; S Pahwa
Journal:  J Immunol Methods       Date:  1991-03-01       Impact factor: 2.303

6.  Immunoglobulin-specific T-B cell interaction. III. B cell activation by immunoglobulin-recognizing T cell clones.

Authors:  S M Mazel; A Y Rudensky; V L Yurin
Journal:  Eur J Immunol       Date:  1990-04       Impact factor: 5.532

7.  Sequence analysis of peptides bound to MHC class II molecules.

Authors:  A Rudensky; P Preston-Hurlburt; S C Hong; A Barlow; C A Janeway
Journal:  Nature       Date:  1991-10-17       Impact factor: 49.962

8.  Effect of pH on MHC class II-peptide interactions.

Authors:  A Sette; S Southwood; D O'Sullivan; F C Gaeta; J Sidney; H M Grey
Journal:  J Immunol       Date:  1992-02-01       Impact factor: 5.422

Review 9.  Lymphokine control of in vivo immunoglobulin isotype selection.

Authors:  F D Finkelman; J Holmes; I M Katona; J F Urban; M P Beckmann; L S Park; K A Schooley; R L Coffman; T R Mosmann; W E Paul
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

10.  Recognition of peptides that are immunopathogenic but cryptic. Mechanisms that allow lymphocytes sensitized against cryptic peptides to initiate pathogenic autoimmune processes.

Authors:  W J Lipham; T M Redmond; H Takahashi; J A Berzofsky; B Wiggert; G J Chader; I Gery
Journal:  J Immunol       Date:  1991-06-01       Impact factor: 5.422

View more
  42 in total

1.  Immune response of SLE patients to peptides based on the complementarity determining regions of a pathogenic anti-DNA monoclonal antibody.

Authors:  M Dayan; R Segal; Z Sthoeger; A Waisman; N Brosh; O Elkayam; E Eilat; M Fridkin; E Mozes
Journal:  J Clin Immunol       Date:  2000-05       Impact factor: 8.317

2.  Amphipathic variable region heavy chain peptides derived from monoclonal human Wegener's anti-PR3 antibodies stimulate lymphocytes from patients with Wegener's granulomatosis and microscopic polyangiitis.

Authors:  E Peen; C Malone; C Myers; R C Williams; A B Peck; E Csernok; W L Gross; R Staud
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

3.  Prevention of systemic lupus erythematosus-like disease in (NZBxNZW)F1 mice by treating with CDR1- and CDR3-based peptides of a pathogenic autoantibody.

Authors:  E Eilat; H Zinger; A Nyska; E Mozes
Journal:  J Clin Immunol       Date:  2000-07       Impact factor: 8.317

4.  Activation of natural killer T cells in NZB/W mice induces Th1-type immune responses exacerbating lupus.

Authors:  Defu Zeng; Yinping Liu; Stephane Sidobre; Mitchell Kronenberg; Samuel Strober
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

5.  Activation of diverse repertoires of autoreactive T cells enhances the loss of anti-dsDNA B cell tolerance.

Authors:  Brian W Busser; Brigette S Adair; Jan Erikson; Terri M Laufer
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

Review 6.  SLE: translating lessons from model systems to human disease.

Authors:  Ram Raj Singh
Journal:  Trends Immunol       Date:  2005-09-09       Impact factor: 16.687

Review 7.  T-helper cell intrinsic defects in lupus that break peripheral tolerance to nuclear autoantigens.

Authors:  Syamal K Datta; Li Zhang; Luting Xu
Journal:  J Mol Med (Berl)       Date:  2005-01-04       Impact factor: 4.599

8.  T cell reactivity against the SmD1(83-119) C terminal peptide in patients with systemic lupus erythematosus.

Authors:  G Riemekasten; C Weiss; S Schneider; A Thiel; A Bruns; F Schumann; S Bläss; G-R Burmester; F Hiepe
Journal:  Ann Rheum Dis       Date:  2002-09       Impact factor: 19.103

9.  Amelioration of lupus manifestations by a peptide based on the complementarity determining region 1 of an autoantibody in severe combined immunodeficient (SCID) mice engrafted with peripheral blood lymphocytes of systemic lupus erythematosus (SLE) patients.

Authors:  N Mauermann; Z Sthoeger; H Zinger; E Mozes
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

Review 10.  Somatic mutagenesis in autoimmunity.

Authors:  Thiago Detanico; James B St Clair; Katja Aviszus; Greg Kirchenbaum; Wenzhong Guo; Lawrence J Wysocki
Journal:  Autoimmunity       Date:  2013-01-18       Impact factor: 2.815

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.